Non-Interventional Study of Cough Variant Asthma Treatment With Pulmicort®Respules® in Children Outpatients
Completed
- Conditions
- Cough Variant Asthma
- Registration Number
- NCT00660114
- Lead Sponsor
- AstraZeneca
- Brief Summary
This open label, non-interventional study is to show the efficacy of Pulmicort®Respules® in cough variant asthma in patient aged 5-year old or younger in outpatient department
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 914
Inclusion Criteria
- Provision of informed consent
- Patient who has been prescribed Pulmicort® Respules® according to physician's judgement, irrespective of the inclusion in the study.
- The usage of Pulmicort® Respules® follows local authorised package insert.
Read More
Exclusion Criteria
- Allergy to any ingredient of Pulmicort® Respules®
- With history of Leukotriene Modifier (LM) usage prior to 2 weeks of recruitment or following plan.
- Have used systemic/inhaled steroid prior to 2 weeks of recruitment
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient Symptom Score 7 weeks (plus or minus 3 days )
- Secondary Outcome Measures
Name Time Method Patient Compliance Report 7 weeks (plus or minus 3 days ) Investigator Assessment Report 7 weeks (plus or minus 3 days )
Trial Locations
- Locations (1)
Research Site
🇨🇳Wenzhou, Zhejiang, China